Labcorp’s Post

Did you know that antibody-drug conjugates (ADCs) are powerful therapies against HER2-positive cancers? These potent targeted treatments combine target-specific antibodies with chemotherapy, delivering therapy directly to cancer cells. HER2, pan-tumor immunohistochemistry testing helps identify patients who might benefit. Learn more: http://spr.ly/6040QLoAp